Cancer Research · 2004 · 106 citations · 21 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyDendritic Cell BiologyT Cell Responses To TumorsTumor Immune MicroenvironmentTumor-infiltrating LymphocytesAntigen-specific Memory ResponsesAntitumor Immune MemoryMelanoma ImmunotherapyMelanoma RegressionSpontaneous Tumor RegressionT Cell-mediated Immune ResponseT-cell Immune ResponsesT-cell Mediated Immune Response
The clinical relevance of dendritic cells (DCs) at the tumor site remains a matter of debate concerning their role in the generation of effective antitumor immunity in human cancers. We performed a comprehensive immunohistochemical analysis using a panel of DC-specific antibodies on regressing tumor lesions and sentinel lymph nodes (SLNs) in melanoma patients. Here we show in a case report involving spontaneous regression of metastatic melanoma that the accumulation of DC-Lamp+ DCs, clustered with tumor cells and lymphocytes, is associated with local expansion of antigen-specific memory effector CTLs. These findings were extended in a series of 19 melanoma-positive SLNs and demonstrated a significant correlation between the density of DC-Lamp+ DC infiltrates in SLNs with the absence of metastasis in downstream lymph nodes. This study, albeit performed in a limited series of patients, points to a pivotal role of mature DCs in the local expansion of efficient antitumor T-cell-mediated immune responses at the initial sites of metastasis and may have important implications regarding the prognosis, staging, and immunotherapy of melanoma patients.
21
Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells
Frank O. Nestlé, Selma Alijagic, Michel Gilliet et al. · Nature Medicine · 1998 · 2.9K citations
Medicine, Immunology, Oncology +14
Marie‐Caroline Dieu‐Nosjean, Béatrice Vanbervliet, Alain Vicari et al. · The Journal of Experimental Medicine · 1998 · 1.4K citations · Full text